🇺🇸 FDA
Pipeline program

Mesalazine

ASA withdrawal study

Unknown small_molecule completed

Quick answer

Mesalazine for Colitis, Ulcerative is a Unknown program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Colitis, Ulcerative
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials